Adriana Rossi
- Hematology top 2%
- Multiple Myeloma Research and Treatments 58
- Acute Myeloid Leukemia Research 5
- Oncology top 10%
- CAR-T cell therapy research 20
- Cancer Treatment and Pharmacology 10
- Peptidase Inhibition and Analysis 9
- Transplantation top 10%
-
- Protein Degradation and Inhibitors 19
-
- Chronic Lymphocytic Leukemia Research 7
-
- Biosimilars and Bioanalytical Methods 8
- Co-authors
- Rubén NiesvizkyRoger PearseTomer M. MarkMorton ColemanDavid JayabalanW. Robert MorrowJeffery A. TowbinKaren Pekle
- Cited by
- HematologyOncologyTransplantation
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Adriana Rossi
80 papers receiving 731 citations
Peers
Comparison fields: 5 of 70
- Hematology 421
- Oncology 394
- Transplantation 23
- Molecular Biology 317
- Genetics 47
Countries citing papers authored by Adriana Rossi
This map shows the geographic impact of Adriana Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana Rossi more than expected).
Fields of papers citing papers by Adriana Rossi
This network shows the impact of papers produced by Adriana Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana Rossi. The network helps show where Adriana Rossi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adriana Rossi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 56 | |
| 11 | 2023 | 35 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 18 | |
| 15 | 2019 | 17 | |
| 16 | 2018 | 0 | |
| 17 | 2017 | 6 | |
| 18 | 2017 | 1 | |
| 19 | 2016 | 4 | |
| 20 | 2000 | 21 |
About Adriana Rossi
Adriana Rossi is a scholar working on Hematology, Oncology and Genetics, having authored 94 papers that have together received 745 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (58 papers), CAR-T cell therapy research (20 papers), Protein Degradation and Inhibitors (19 papers), Cancer Treatment and Pharmacology (10 papers), Peptidase Inhibition and Analysis (9 papers), Biosimilars and Bioanalytical Methods (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Hematology (421 citations), Oncology (394 citations) and Transplantation (23 citations). Adriana Rossi has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Rubén Niesvizky, Roger Pearse, Tomer M. Mark, Morton Coleman, David Jayabalan, W. Robert Morrow, Jeffery A. Towbin, Karen Pekle, Robert E. Shaddy and Juan Alejos.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.